● Recruiting

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

Condition: Advanced Solid Tumor · Ovarian Cancer · Endometrial Cancer · Sponsor: TORL Biotherapeutics, LLC

PhasePhase 1

Planned participants90

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with advanced cancer

This description comes directly from the study's public registry record.

Talk to the study team

Nora Ku, MD · 310-348-9636 · nora.ku@torlbio.com

Ibrahim Qazi · 310-348-9636

Always discuss trial participation with your own doctor first.

Locations (14)

Providence Medical Foundation	Fullerton, California, United States	Recruiting
UCLA - JCCC Clinical Research Unit	Los Angeles, California, United States	Recruiting
University of Kentucky Medical Center	Lexington, Kentucky, United States	Recruiting
University of Minnesota	Minneapolis, Minnesota, United States	Recruiting
Mayo Clinic in Rochester	Rochester, Minnesota, United States	Recruiting
Memorial Sloan Kettering Cancer Center	New York, New York, United States	Recruiting
Cleveland Clinic	Cleveland, Ohio, United States	Recruiting
Sarah Cannon Research Institute Texas Oncology	Tyler, Texas, United States	Recruiting
Virginia Cancer Specialists	Fairfax, Virginia, United States	Recruiting
St. Vincent's Hospital, The Catholic University of Korea	Suwon, Gyeonggi-do, South Korea	Recruiting
Seoul National University Hospital	Seoul, South Korea	Recruiting
Severance Hospital	Seoul, South Korea	Recruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05103683